[HTML] sciencedirect.com

[HTML][HTML] Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias

I Castela, R Casado-Polanco, YVW Rubio… - Neurobiology of …, 2023 - Elsevier
Levodopa (L-DOPA) administration remains the gold standard therapy for Parkinson's
disease (PD). Despite several pharmacological advances in the use of L-DOPA, a high …
被引用次数：10 相关文章

Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias

I Castela, R Casado-Polanco, YVW Rubio, JA da Silva… - 2023 - digital.csic.es
Levodopa (L-DOPA) administration remains the gold standard therapy for Parkinson's
disease (PD). Despite several pharmacological advances in the use of L-DOPA, a high …

SELECTIVE ACTIVATION OF STRIATAL INDIRECT PATHWAY SUPPRESSES LEVODOPA-INDUCED DYSKINESIAS

I Castela, YVW Rubio… - IBRO Neuroscience …, 2023 - ibroneuroreports.org
Levodopa (L-DOPA) administration remains the gold standard therapy for Parkinson
disease (PD). Despite several pharmacological advances in the use of L-DOPA, a high …

Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias.

I Castela, R Casado-Polanco, YV Rubio… - Neurobiology of …, 2022 - europepmc.org
Levodopa (L-DOPA) administration remains the gold standard therapy for Parkinson's
disease (PD). Despite several pharmacological advances in the use of L-DOPA, a high …

Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias

I Castela, R Casado-Polanco… - Neurobiology of …, 2023 - pubmed.ncbi.nlm.nih.gov
Levodopa (L-DOPA) administration remains the gold standard therapy for Parkinson's
disease (PD). Despite several pharmacological advances in the use of L-DOPA, a high …